---
title: "欧化预计中期净亏损大幅收窄至不多于 300 万港元"
description: "智通财经 APP 讯，欧化发布公告，集团截至 2025 年 9 月 30 日止六个月的净亏损预期将大幅收窄至不多于 300 万港元 (2024 年：1100 万港元)，主要是由于集团于本期间实施了有效的成本控制措施。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/262255973.md"
published_at: "2025-10-22T13:05:02.000Z"
---

# 欧化预计中期净亏损大幅收窄至不多于 300 万港元

> 智通财经 APP 讯，欧化发布公告，集团截至 2025 年 9 月 30 日止六个月的净亏损预期将大幅收窄至不多于 300 万港元 (2024 年：1100 万港元)，主要是由于集团于本期间实施了有效的成本控制措施。

智通财经 APP 讯，欧化 (01711) 发布公告，集团截至 2025 年 9 月 30 日止六个月的净亏损预期将大幅收窄至不多于 300 万港元 (2024 年：1100 万港元)，主要是由于集团于本期间实施了有效的成本控制措施。

### Related Stocks

- [01711.HK - 欧化](https://longbridge.com/zh-CN/quote/01711.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Ulferts International sees group's HY net loss to narrow to not more than HK$3 million | Ulferts International sees group's HY net loss to narrow to not more than HK$3 million | [Link](https://longbridge.com/zh-CN/news/262272520.md) |
| Ulferts International Limited Reports Narrowed Net Loss for 2025 | Ulferts International Limited Reports Narrowed Net Loss for 2025 | [Link](https://longbridge.com/zh-CN/news/262260314.md) |
| Biltmore Family Office LLC Reduces Holdings in NVIDIA Corporation $NVDA | Biltmore Family Office LLC reduced its holdings in NVIDIA Corporation (NASDAQ: NVDA) by 9.1% in Q3, now owning 29,694 sh | [Link](https://longbridge.com/zh-CN/news/275999991.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/zh-CN/news/276051793.md) |
| NVIDIA new chips to cut costs by 35x as coding tools grab half of AI related searches | NVIDIA has launched its GB300 NVL72 systems, which significantly improve efficiency by processing 50 times more work per | [Link](https://longbridge.com/zh-CN/news/276081422.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。